This method could usher in a new approach to delivery of drugs in general
Freiburg researchers find purely chemical way to target therapeutic nano-containers to cells
Scientists have discovered that a polymer can provide a key to get into tumors: Prof. Prasad Shastri, Director of the Institute of Macromolecular Chemistry and core member of the cluster of excellence BIOSS Centre for Biological Signalling Studies at the University of Freiburg, and graduate students Julia Voigt and Jon Christensen have developed a new paradigm to home nanoparticles, containers that measure a few 100 nanometers in size, to endothelial cells. Using just charged polymers with the right affinity for cell lipids the team has developed nanoparticles that can recognize specific cell types simply by their chemical properties. “This is a remarkable discovery, as it allows for the first time to target a specific cell type purely through biophysical principles, and without using the traditional ligand-receptor approach” says Prof. Shastri who led the study that was selected as cover article of the Proceedings of the National Academy of Sciences. Until now researchers placed molecules on nanoparticles that can latch onto proteins on cell surface – called receptors.
These receptors act as an address or a biological postal code. However in tumors these addresses can change rapidly with time. To solve this lack of precision Shastri and team developed particles that are delivered to endothelial cells using a biophysical approach. “This delivery approach does not require a biological postal code for targeting of nanoparticles and is an important step forward in developing nanoparticle based systems for treating cancers” says Julia Voigt the lead author of the paper.
Cancers are very hungry tissues and they need constant nourishment. This is provided through their own supply of blood vessels. “By going after endothelial cells that make up these blood vessels, we can starve the tumor or kill it with one payload” says Jon Christensen who is a co-author on this study and works on tumor metastasis.
Nanoparticles are used to deliver therapeutics in treating cancers. These very small pills, cornerstones of nanomedicine, get injected into the body and reach the tumor cells via the bloodstream. When they find the targeted cells, they need to be eaten so that the drug can act within the cell.
The Latest on: Nanomedicine
[google_news title=”” keyword=”Nanomedicine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Nanomedicine
- Clene (NASDAQ: CLNN) Releases Q1 2024 Financial Numbers, Operation Highlightson May 9, 2024 at 7:07 am
To view the full press release, visit Clene and its wholly owned subsidiary, Clene Nanomedicine, is a late-clinical-stage biopharmaceutical company focused on improving mitochondrial health and ...
- Biomednewsbreaks - Clene Inc. (NASDAQ: CLNN) Releases Q1 2024 Financial Numbers, Operation Highlightson May 8, 2024 at 12:16 pm
Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., are reporting on first-quarter 2024 financial results and operat ...
- Enabling rapid screening of poly(2-oxazoline)-based nanomedicine through divergent synthesison May 8, 2024 at 8:20 am
A research collaboration has devised a new way to quickly and reliably diversify the reactive end-groups on poly(2-oxazoline)s, a biocompatible polymer class. Their approach enables quick exploration ...
- Clene Reports First Quarter 2024 Financial Results and Recent Operating Highlightson May 8, 2024 at 1:00 am
SALT LAKE CITY, May 08, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine, Inc., a late clinical-stage ...
- Liposomal Nanomedicine for Breast Cancer Therapyon May 7, 2024 at 5:00 pm
Size is one of the decisive characteristics of liposomes for advanced chemotherapy of tumors. Larger sized liposomes are effectively taken up by the reticuloendothelial system (RES) and cleared ...
- Breakthrough Nanoparticle Targets Breast Cancer and Brain Tumorson May 7, 2024 at 9:04 am
In a recent study published in Proceedings of the National Academy of Sciences, scientists at the University of Miami Miller School of Medicine's Sylvester Comprehensive Cancer Center developed a ...
- Green Biomaterials for Tissue Engineering and Nanomedicine Applications: Recent Advances and Future Trendson May 7, 2024 at 7:22 am
The global ecological burden that includes the progressive fossil resources depletion and the simultaneous global population growth and waste production intensification, requires adequate efforts for ...
- Enabling rapid screening of poly(2-oxazoline)-based nanomedicine through divergent synthesis; towards alternative mRNA-vaccineson May 5, 2024 at 5:00 pm
A collaboration between Leiden University (Assistant Prof. Joachim F. R. Van Guyse) and the Innovation Center for NanoMedicine (iCONM; Center Director: Prof. Kazunori Kataoka), a research institute of ...
- ‘Liquid gold’ could bring new hope to multiple sclerosis patients, study suggests: ‘Profound benefit’on April 30, 2024 at 2:30 am
An experimental medication called CNM-Au8 — a drinkable liquid with gold nanocrystals — has shown promising results in clinical trials for improving MS symptoms. Doctors and researchers weighed in.
- Raman Spectroscopy in Nanomedicineon April 5, 2024 at 5:00 pm
Nanomedicine. 2013;8(8):1335-1351. Spontaneous Raman spectroscopy has, therefore, already been demonstrated to be a chemically specific method for investigating nanoparticle interactions and to ...
via Bing News